---
title: "Pliant Therapeutics: Strange Volatility"
date: "2025-02-11 08:31:37"
summary: "Pgiam/iStock via Getty Images  Note the following timeline: On Feb. 07, 2025 at 4:58 PM ET, Pliant Therapeutics (NASDAQ:PLRX) made a major announcement—the company was voluntarily pausing the phase 2b/3 trial of bexotegrast in patients with"
categories:
  - "seekalpha_articles"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha_articles"
menu: ""
thumbnail: "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1220627489/image_1220627489.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

![Business on Wall Street in Manhattan](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1220627489/image_1220627489.jpg?io=getty-c-w750) 



Pgiam/iStock via Getty Images





Note the following timeline:

On Feb. 07, 2025 at 4:58 PM ET, Pliant Therapeutics (NASDAQ:[PLRX](https://seekingalpha.com/symbol/PLRX "Pliant Therapeutics, Inc.")) made a major [announcement](https://ir.pliantrx.com/node/10111/pdf)—the company was voluntarily pausing the phase 2b/3 trial of bexotegrast in patients with

[seekalpha_articles](https://seekingalpha.com/article/4756829-pliant-therapeutics-stock-strange-volatility-confusing-trial-data-avoid)
